{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:39:14Z","timestamp":1792075154846,"version":"4.4.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41585-026-01126-x","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T17:02:03Z","timestamp":1769446923000},"page":"517-532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term adverse effects of modern Wilms tumour therapies: implications for monitoring"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-3509","authenticated-orcid":false,"given":"Filippo","family":"Spreafico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gattuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta G.","family":"Podda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Vennarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7350-4475","authenticated-orcid":false,"given":"Giovanni","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Massimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Terenziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"1126_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-021-00308-8","volume":"7","author":"F Spreafico","year":"2021","unstructured":"Spreafico, F. et al. Wilms tumour. Nat. Rev. Dis. Primers 7, 75 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1126_CR2","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1093\/hmg\/ddaa091","volume":"29","author":"JL Maciaszek","year":"2020","unstructured":"Maciaszek, J. L., Oak, N. & Nichols, K. E. Recent advances in Wilms\u2019 tumor predisposition. Hum. Mol. Genet. 29, R138\u2013R149 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"1126_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher, E. et al. International incidence of childhood cancer, 2001\u201310: a population-based registry study. Lancet Oncol. 18, 719\u2013731 (2017).","journal-title":"Lancet Oncol."},{"key":"1126_CR4","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","volume":"390","author":"N Bhakta","year":"2017","unstructured":"Bhakta, N. et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet 390, 2569\u20132582 (2017).","journal-title":"Lancet"},{"key":"1126_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2023.16875","volume":"330","author":"S Bhatia","year":"2023","unstructured":"Bhatia, S., Tonorezos, E. S. & Landier, W. Clinical care for people who survive childhood cancer: a review. JAMA 330, 1175\u20131186 (2023).","journal-title":"JAMA"},{"key":"1126_CR6","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/pbc.23090","volume":"57","author":"AM Termuhlen","year":"2011","unstructured":"Termuhlen, A. M. et al. Twenty-five year follow-up of childhood wilms tumor: a report from the childhood cancer survivor study. Pediatr. Blood Cancer 57, 1210\u20131216 (2011).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR7","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger, K. C. et al. Chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med. 355, 1572\u20131582 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1126_CR8","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1200\/JCO.22.02111","volume":"41","author":"BR Weil","year":"2023","unstructured":"Weil, B. R. et al. Late health outcomes among survivors of wilms tumor diagnosed over three decades: a report from the childhood cancer survivor study. J. Clin. Oncol. 41, 2638\u20132650 (2023).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-056918","volume":"150","author":"KL Foster","year":"2022","unstructured":"Foster, K. L. et al. Clinical assessment of late health outcomes in survivors of wilms tumor. Pediatrics 150, e2022056918 (2022).","journal-title":"Pediatrics"},{"key":"1126_CR10","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","volume":"31","author":"GT Armstrong","year":"2013","unstructured":"Armstrong, G. T. et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J. Clin. Oncol. 31, 3673\u20133680 (2013).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR11","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ijc.23333","volume":"122","author":"AJ Taylor","year":"2008","unstructured":"Taylor, A. J. et al. Second primary neoplasms in survivors of Wilms\u2019 tumour \u2014 a population-based cohort study from the british childhood cancer survivor study. Int. J. Cancer 122, 2085\u20132093 (2008).","journal-title":"Int. J. Cancer"},{"key":"1126_CR12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/pbc.22518","volume":"55","author":"MM Geenen","year":"2010","unstructured":"Geenen, M. M., Bakker, P. J. M., Kremer, L. C. M., Kastelein, J. J. P. & Leeuwen, F. E. V. Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy. Pediatr. Blood Cancer 55, 690\u2013697 (2010).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1056\/NEJMoa1510795","volume":"374","author":"GT Armstrong","year":"2016","unstructured":"Armstrong, G. T. et al. Reduction in Late mortality among 5-year survivors of childhood cancer. N. Engl. J. Med. 374, 833\u2013842 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1126_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1470-2045(19)30800-9","volume":"21","author":"E Suh","year":"2020","unstructured":"Suh, E. et al. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the childhood cancer survivor study. Lancet Oncol. 21, 421\u2013435 (2020).","journal-title":"Lancet Oncol."},{"key":"1126_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/S1470-2045(14)70408-5","volume":"15","author":"DM Green","year":"2014","unstructured":"Green, D. M. et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St. Jude lifetime cohort study. Lancet Oncol. 15, 1215\u20131223 (2014).","journal-title":"Lancet Oncol."},{"key":"1126_CR16","doi-asserted-by":"publisher","first-page":"110961","DOI":"10.1016\/j.radonc.2025.110961","volume":"209","author":"FSPL Wens","year":"2025","unstructured":"Wens, F. S. P. L. et al. Late toxicity after upper abdominal radiotherapy in pediatric Wilms tumor and neuroblastoma survivors. A systematic review on behalf of SIOPEN and SIOP\u2013RTSG. Radiother. Oncol. 209, 110961 (2025).","journal-title":"Radiother. Oncol."},{"key":"1126_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00467-023-06213-4","volume":"39","author":"F Spreafico","year":"2024","unstructured":"Spreafico, F., Biasoni, D. & Montini, G. Most appropriate surgical approach in children with Wilms tumour, risk of kidney disease, and related considerations. Pediatric Nephrol. 39, 1019\u20131022 (2024).","journal-title":"Pediatric Nephrol."},{"key":"1126_CR18","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1002\/cncr.29373","volume":"121","author":"RB Interiano","year":"2015","unstructured":"Interiano, R. B. et al. Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy. Cancer 121, 2449\u20132456 (2015).","journal-title":"Cancer"},{"key":"1126_CR19","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00467-024-06624-x","volume":"40","author":"S Reinert","year":"2025","unstructured":"Reinert, S., Benoit, S. W. & Nagarajan, R. Long-term kidney outcomes in survivors of Wilms tumor: a single-center retrospective cohort study. Pediatric Nephrol. 40, 1603\u20131611 (2025).","journal-title":"Pediatric Nephrol."},{"key":"1126_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/S41585-025-01055-1","author":"DJ Benedetti","year":"2025","unstructured":"Benedetti, D. J. et al. Updated favourable-histology Wilms tumour risk stratification: rationale for future Children\u2019s Oncology Group clinical trials. Nat. Rev. Urol. https:\/\/doi.org\/10.1038\/S41585-025-01055-1 (2025).","journal-title":"Nat. Rev. Urol."},{"key":"1126_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.6004\/jnccn.2021.7070","volume":"19","author":"JS Dome","year":"2021","unstructured":"Dome, J. S. et al. Impact of the first generation of children\u2019s oncology group clinical trials on clinical practice for wilms tumor. J. Natl Compr. Cancer Netw. 19, 978\u2013985 (2021).","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"1126_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30153","volume":"70","author":"MV Ortiz","year":"2023","unstructured":"Ortiz, M. V. et al. Advances in the clinical management of high-risk Wilms tumors. Pediatr. Blood Cancer 70, e30153 (2023).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30586","volume":"70","author":"JI Geller","year":"2023","unstructured":"Geller, J. I. et al. Children\u2019s Oncology Group\u2019s 2023 blueprint for research: renal tumors. Pediatr. Blood Cancer 70, e30586 (2023).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrurol.2017.163","volume":"14","author":"MM Van Den Heuvel-Eibrink","year":"2017","unstructured":"Van Den Heuvel-Eibrink, M. M. et al. Position Paper: rationale for the treatment of wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat. Rev. Urol. 14, 743\u2013752 (2017).","journal-title":"Nat. Rev. Urol."},{"key":"1126_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s43018-024-00745-w","volume":"5","author":"JG Guida","year":"2024","unstructured":"Guida, J. G. et al. Associations of seven measures of biological age acceleration with frailty and all-cause mortality among adult survivors of childhood cancer in the St. Jude Lifetine cohort. Nat. Cancer. May 5, 731\u2013741 (2024).","journal-title":"Nat. Cancer. May"},{"key":"1126_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jamaoncol.2025.0236","volume":"11","author":"JM Yeh","year":"2025","unstructured":"Yeh, J. M. et al. Accelerated aging in survivors of childhood cancer-early onset and excess risk of chronic conditions. JAMA Oncol. 11, 535\u2013543 (2025).","journal-title":"JAMA Oncol."},{"key":"1126_CR27","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1200\/JCO.2017.76.7467","volume":"36","author":"KK Ness","year":"2018","unstructured":"Ness, K. K. et al. Premature physiologic aging as a paradigm for understanding increased risk of adverse health across the lifespan of survivors of childhood cancer. J. Clin. Oncol. 36, 2206\u20132215 (2018).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mpo.1316","volume":"38","author":"LL Robison","year":"2002","unstructured":"Robison, L. L. et al. Study design and cohort characteristics of the childhood cancer survivor study: a multi-institutional collaborative project. Med. Pediatr. Oncol. 38, 229\u2013239 (2002).","journal-title":"Med. Pediatr. Oncol."},{"key":"1126_CR29","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S1470-2045(18)30537-0","volume":"19","author":"TM Gibson","year":"2018","unstructured":"Gibson, T. M. et al. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970\u201399: a report from the childhood cancer survivor study cohort. Lancet Oncol. 19, 1590\u20131601 (2018).","journal-title":"Lancet Oncol."},{"key":"1126_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28271","volume":"67","author":"DM Green","year":"2020","unstructured":"Green, D. M. et al. Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study. Pediatr. Blood Cancer 67, e28271 (2020).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR31","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1200\/JCO.2015.64.4344","volume":"34","author":"KF Wong","year":"2016","unstructured":"Wong, K. F. et al. Risk of adverse health and social outcomes up to 50 years after wilms tumor: the british childhood cancer survivor study. J. Clin. Oncol. 34, 1772\u20131779 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ijc.33817","volume":"150","author":"J Byrne","year":"2022","unstructured":"Byrne, J. et al. Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: the PanCareSurFup consortium. Int. J. Cancer 150, 406\u2013419 (2022).","journal-title":"Int. J. Cancer"},{"key":"1126_CR33","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jamaoncol.2022.4649","volume":"8","author":"TO Henderson","year":"2022","unstructured":"Henderson, T. O. et al. Association of changes in cancer therapy over 3 decades with risk of subsequent breast cancer among female childhood cancer survivors: a report from the childhood cancer survivor study (CCSS). JAMA Oncol. 8, 1765\u20131774 (2022).","journal-title":"JAMA Oncol."},{"key":"1126_CR34","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.annonc.2021.08.1749","volume":"32","author":"N Graf","year":"2021","unstructured":"Graf, N. et al. Fifty years of clinical and research studies for childhood renal tumors within the International society of pediatric oncology (SIOP). Ann. Oncol. 32, 1327\u20131331 (2021).","journal-title":"Ann. Oncol."},{"key":"1126_CR35","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/S0140-6736(14)62395-3","volume":"386","author":"K Pritchard-Jones","year":"2015","unstructured":"Pritchard-Jones, K. et al. Omission of doxorubicin from the treatment of stage II\u2013III, intermediate-risk Wilms\u2019 tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet 386, 1156\u20131164 (2015).","journal-title":"Lancet"},{"key":"1126_CR36","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/SLA.0000000000001716","volume":"265","author":"CV Fernandez","year":"2017","unstructured":"Fernandez, C. V. et al. Clinical outcome and biological predictors of relapse after nephrectomy only for very low-risk wilms tumor. Ann. Surg. 265, 835\u2013840 (2017).","journal-title":"Ann. Surg."},{"key":"1126_CR37","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1200\/JCO.18.01972","volume":"37","author":"DB Dix","year":"2019","unstructured":"Dix, D. B. et al. Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor: a children\u2019s oncology group AREN0532 and AREN0533 study report. J. Clin. Oncol. 37, 2769\u20132777 (2019).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR38","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1016\/j.prro.2018.07.005","volume":"9","author":"JA Kalapurakal","year":"2019","unstructured":"Kalapurakal, J. A. et al. Cardiac-Sparing whole lung intensity modulated radiation therapy in children with wilms tumor: final report on technique and abdominal field matching to maximize normal tissue protection. Pract. Radiat. Oncol. 9, e62\u2013e73 (2019).","journal-title":"Pract. Radiat. Oncol."},{"key":"1126_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijrobp.2009.01.046","volume":"76","author":"JA Kalapurakal","year":"2010","unstructured":"Kalapurakal, J. A. et al. Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A Report From the National Wilms Tumor Study Group. Int. J. Radiat. Oncol. Biol. Phys. 76, 201\u2013206 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1126_CR40","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S2352-4642(20)30183-8","volume":"4","author":"GO Janssens","year":"2020","unstructured":"Janssens, G. O. et al. The SIOP\u2013Renal tumour study group consensus statement on flank target volume delineation for highly conformal radiotherapy. Lancet Child. Adolesc. Health 4, 846\u2013852 (2020).","journal-title":"Lancet Child. Adolesc. Health"},{"key":"1126_CR41","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1002\/cncr.32958","volume":"126","author":"PF Ehrlich","year":"2020","unstructured":"Ehrlich, P. F. et al. Results of treatment for patients with multicentric or bilaterally predisposed unilateral wilms tumor (AREN0534): a report from the children\u2019s oncology group. Cancer 126, 3516\u20133525 (2020).","journal-title":"Cancer"},{"key":"1126_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1200\/JCO.2009.24.9037","volume":"28","author":"DM Green","year":"2010","unstructured":"Green, D. M. et al. Fertility of male survivors of childhood cancer: a report from the childhood cancer survivor study. J. Clin. Oncol. 28, 332\u2013339 (2010).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR43","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1210\/jc.2016-3723","volume":"102","author":"W Chemaitilly","year":"2017","unstructured":"Chemaitilly, W. et al. Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude lifetime cohort. J. Clin. Endocrinol. Metab. 102, 2242\u20132250 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1126_CR44","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/humrep\/dey229","volume":"33","author":"MH Van Den Berg","year":"2018","unstructured":"Van Den Berg, M. H. et al. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve. Hum. Reprod. 33, 1474\u20131488 (2018).","journal-title":"Hum. Reprod."},{"key":"1126_CR45","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.18.00965","volume":"37","author":"V Lehmann","year":"2019","unstructured":"Lehmann, V. et al. Gonadal functioning and perceptions of infertility risk among adult survivors of childhood cancer: a report from the st jude lifetime cohort study. J. Clin. Oncol. 37, 893\u2013902 (2019).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR46","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ijc.34006","volume":"151","author":"MEM van der Perk","year":"2022","unstructured":"van der Perk, M. E. M. et al. White paper: oncofertility in pediatric patients with Wilms tumor. Int. J. Cancer 151, 843\u2013858 (2022).","journal-title":"Int. J. Cancer"},{"key":"1126_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/pbc.24679","volume":"61","author":"DM Green","year":"2014","unstructured":"Green, D. M. et al. The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the childhood cancer survivor study. Pediatr. Blood Cancer 61, 53\u201367 (2014).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/pbc.21780","volume":"52","author":"NJ Van Casteren","year":"2009","unstructured":"Van Casteren, N. J. et al. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr. Blood Cancer 52, 108\u2013112 (2009).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR49","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1001\/jama.1988.03720140043031","volume":"259","author":"SA Rivkees","year":"1988","unstructured":"Rivkees, S. A. et al. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 259, 2123\u20132125 (1988).","journal-title":"JAMA"},{"key":"1126_CR50","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1210\/clinem\/dgaa172","volume":"105","author":"H Irene Su","year":"2020","unstructured":"Irene Su, H. et al. Modeling variation in the reproductive lifespan of female adolescent and young adult cancer survivors using AMH. J. Clin. Endocrinol. Metab. 105, 2740\u20132751 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1126_CR51","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/humrep\/der435","volume":"27","author":"CP Hagen","year":"2012","unstructured":"Hagen, C. P. et al. Individual serum levels of anti-Mllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum. Reprod. 27, 861\u2013866 (2012).","journal-title":"Hum. Reprod."},{"key":"1126_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10815-017-1058-4","volume":"35","author":"LM Pastore","year":"2018","unstructured":"Pastore, L. M., Christianson, M. S., Stelling, J., Kearns, W. G. & Segars, J. H. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR. J. Assist. Reprod. Genet. 35, 17\u201323 (2018).","journal-title":"J. Assist. Reprod. Genet."},{"key":"1126_CR53","doi-asserted-by":"publisher","unstructured":"Panay, N. et al. Evidence-based guideline: premature ovarian insufficiency. Hum. Reprod. Open https:\/\/doi.org\/10.1093\/hropen\/hoae065 (2024).","DOI":"10.1093\/hropen\/hoae065"},{"key":"1126_CR54","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","volume":"22","author":"RL Mulder","year":"2021","unstructured":"Mulder, R. L. et al. Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE consortium and the international late effects of childhood cancer guideline harmonization group. Lancet Oncol. 22, e45\u2013e56 (2021).","journal-title":"Lancet Oncol."},{"key":"1126_CR55","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","volume":"36","author":"W Van Dorp","year":"2018","unstructured":"Van Dorp, W. et al. Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review. J. Clin. Oncol. 36, 2169\u20132180 (2018).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR56","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ijrobp.2024.03.032","volume":"120","author":"I Diallo","year":"2024","unstructured":"Diallo, I. et al. Radiation doses received by major organs at risk in children and young adolescents treated for cancer with external beam radiation therapy: a large-scale study from 12 European countries. Int. J. Radiat. Oncol. Biol. Phys. 120, 439\u2013453 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1126_CR57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/humrep\/deg016","volume":"18","author":"WHB Wallace","year":"2003","unstructured":"Wallace, W. H. B., Thomson, A. B. & Kelsey, T. W. The radiosensitivity of the human oocyte. Hum. Reprod. 18, 117\u2013121 (2003).","journal-title":"Hum. Reprod."},{"key":"1126_CR58","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ijrobp.2023.03.045","volume":"119","author":"JE Bates","year":"2024","unstructured":"Bates, J. E. et al. Cardiac disease in childhood cancer survivors treated with radiation therapy: a pentec comprehensive review. Int. J. Radiat. Oncol. Biol. Phys. 119, 522\u2013532 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1126_CR59","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1089\/jayao.2020.0012","volume":"9","author":"LR Meacham","year":"2020","unstructured":"Meacham, L. R., Burns, K., Orwig, K. E. & Levine, J. Standardizing risk assessment for treatment-related gonadal insufficiency and infertility in childhood adolescent and young adult cancer: the pediatric initiative network risk stratification system. J. Adolesc. Young Adult Oncol. 9, 662\u2013666 (2020).","journal-title":"J. Adolesc. Young Adult Oncol."},{"key":"1126_CR60","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S1470-2045(24)00269-9","volume":"25","author":"C Sunguc","year":"2024","unstructured":"Sunguc, C. et al. Risks of adverse obstetric outcomes among female survivors of adolescent and young adult cancer in England (TYACSS): a population-based, retrospective cohort study. Lancet Oncol. 25, 1080\u20131091 (2024).","journal-title":"Lancet Oncol."},{"key":"1126_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28854","volume":"70","author":"MB Moravek","year":"2023","unstructured":"Moravek, M. B. et al. Fertility assessment and treatment in adolescent and young adult cancer survivors. Pediatr. Blood Cancer 70, e28854 (2023).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR62","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/S1470-2045(20)30582-9","volume":"22","author":"RL Mulder","year":"2021","unstructured":"Mulder, R. L. et al. Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE consortium and the international late effects of childhood cancer guideline harmonization group. Lancet Oncol. 22, e57\u2013e67 (2021).","journal-title":"Lancet Oncol."},{"key":"1126_CR63","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/S1470-2045(17)30026-8","volume":"18","author":"R Skinner","year":"2017","unstructured":"Skinner, R. et al. Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late effects of childhood cancer guideline harmonization group in collaboration with the pancaresurfup consortium. Lancet Oncol. 18, e75\u2013e90 (2017).","journal-title":"Lancet Oncol."},{"key":"1126_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11764-014-0354-6","volume":"8","author":"K Wasilewski-Masker","year":"2014","unstructured":"Wasilewski-Masker, K. et al. Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study. J. Cancer Survivorship 8, 437\u2013447 (2014).","journal-title":"J. Cancer Survivorship"},{"key":"1126_CR65","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00467-017-3673-9","volume":"32","author":"MA Neu","year":"2017","unstructured":"Neu, M. A. et al. Prospective analysis of long-term renal function in survivors of childhood Wilms tumor. Pediatric Nephrol. 32, 1915\u20131925 (2017).","journal-title":"Pediatric Nephrol."},{"key":"1126_CR66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpeds.2020.12.005","volume":"230","author":"DI Chu","year":"2021","unstructured":"Chu, D. I. et al. Kidney outcomes and hypertension in survivors of wilms tumor: a prospective cohort study. J. Pediatrics 230, 215\u2013220.e1 (2021).","journal-title":"J. Pediatrics"},{"key":"1126_CR67","doi-asserted-by":"publisher","unstructured":"Knijnenburg, S. L. et al. Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD008944.pub2 (2013).","DOI":"10.1002\/14651858.CD008944.pub2"},{"key":"1126_CR68","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1007\/s00467-022-05460-1","volume":"37","author":"E Arslan","year":"2022","unstructured":"Arslan, E. et al. Increased risk for kidney sequelae surrogates in survivors of Wilms tumor. Pediatric Nephrol. 37, 2415\u20132426 (2022).","journal-title":"Pediatric Nephrol."},{"key":"1126_CR69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpeds.2022.10.029","volume":"255","author":"W Hsiao","year":"2023","unstructured":"Hsiao, W. et al. Long-Term Kidney and Cardiovascular Complications in Pediatric Cancer Survivors. J. Pediatrics 255, 89\u201397.e1 (2023).","journal-title":"J. Pediatrics"},{"key":"1126_CR70","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.juro.2011.12.109","volume":"187","author":"DA Cozzi","year":"2012","unstructured":"Cozzi, D. A., Ceccanti, S., Frediani, S., Schiavetti, A. & Cozzi, F. Chronic kidney disease in children with unilateral renal tumor. J. Urol. 187, 1800\u20131805 (2012).","journal-title":"J. Urol."},{"key":"1126_CR71","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1159\/000492951","volume":"43","author":"M Kosiak","year":"2018","unstructured":"Kosiak, M. et al. Sonographic image of solitary kidney in wilms tumour survivors. Kidney Blood Press. Res. 43, 1363\u20131374 (2018).","journal-title":"Kidney Blood Press. Res."},{"key":"1126_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.urolonc.2015.07.002","volume":"34","author":"RLP Romao","year":"2016","unstructured":"Romao, R. L. P. & Lorenzo, A. J. Renal function in patients with Wilms tumor. Urol. Oncol. 34, 33\u201341 (2016).","journal-title":"Urol. Oncol."},{"key":"1126_CR73","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1097\/01.ju.0000176800.00994.3a","volume":"174","author":"NE Breslow","year":"2005","unstructured":"Breslow, N. E. et al. End stage renal disease in patients with Wilms tumor: results from the national wilms tumor study group and the United States renal data system. J. Urol. 174, 1972\u20131975 (2005).","journal-title":"J. Urol."},{"key":"1126_CR74","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.juro.2011.03.110","volume":"186","author":"J Lange","year":"2011","unstructured":"Lange, J. et al. Risk factors for end stage renal disease in non-wt1-syndromic wilms tumor. J. Urol. 186, 378\u2013386 (2011).","journal-title":"J. Urol."},{"key":"1126_CR75","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00467-011-1759-3","volume":"26","author":"J Stefanowicz","year":"2011","unstructured":"Stefanowicz, J. et al. Glomerular filtration rate and prevalence of chronic kidney disease in Wilms\u2019 tumour survivors. Pediatric Nephrol. 26, 759\u2013766 (2011).","journal-title":"Pediatric Nephrol."},{"key":"1126_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31485","volume":"72","author":"DM Green","year":"2025","unstructured":"Green, D. M. et al. Kidney function and body composition in adult survivors of unilateral, non-syndromic wilms tumor: a report from the St. Jude lifetime cohort study. Pediatr. Blood Cancer 72, e31485 (2025).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31172","volume":"71","author":"ET Tracy","year":"2024","unstructured":"Tracy, E. T., Leraas, H., Olson, L., Shamberger, R. C. & Ehrlich, P. F. Wilms tumor characteristics, surgical management, outcomes, and chronic kidney disease in children with WAGR syndrome: a report from the International WAGR syndrome association survey. Pediatr. Blood Cancer 71, e31172 (2024).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR78","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1016\/j.ekir.2024.09.007","volume":"9","author":"SE van Peer","year":"2024","unstructured":"van Peer, S. E. et al. Clinical characterization of a national cohort of patients with germline WT1 variants including late-onset phenotypes. Kidney Int. Rep. 9, 3570\u20133579 (2024).","journal-title":"Kidney Int. Rep."},{"key":"1126_CR79","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejca.2021.06.050","volume":"155","author":"BV Dieffenbach","year":"2021","unstructured":"Dieffenbach, B. V. et al. Late-onset kidney failure in survivors of childhood cancer: a report from the childhood cancer survivor study. Eur. J. Cancer 155, 216\u2013226 (2021).","journal-title":"Eur. J. Cancer"},{"key":"1126_CR80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.euros.2021.01.003","volume":"25","author":"S Groen in\u2019t Woud","year":"2021","unstructured":"Groen in\u2019t Woud, S. et al. Clinical management of children with a congenital solitary functioning kidney: overview and recommendations. Eur. Urol. Open. Sci. 25, 11\u201320 (2021).","journal-title":"Eur. Urol. Open. Sci."},{"key":"1126_CR81","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02534","author":"ECM Kooijmans","year":"2025","unstructured":"Kooijmans, E. C. M. et al. Nephrotoxicity surveillance for childhood and young adult survivors of cancer: recommendations from the international late effects of childhood cancer guideline harmonization group. J. Clin. Oncol. https:\/\/doi.org\/10.1200\/JCO-24-02534 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41585-021-00533-6","volume":"19","author":"F Spreafico","year":"2022","unstructured":"Spreafico, F., Gattuso, G., Nigro, O., Terenziani, M. & Massimino, M. Recommending exercise for children with a single kidney. Nat. Rev. Urol. 19, 65\u201366 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"1126_CR83","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jpurol.2014.06.017","volume":"10","author":"AJM Kern","year":"2014","unstructured":"Kern, A. J. M. et al. Impact of nephrectomy on long-term renal function in non-syndromic children treated for unifocal Wilms tumor. J. Pediatr. Urol. 10, 662\u2013666 (2014).","journal-title":"J. Pediatr. Urol."},{"key":"1126_CR84","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000332083","volume":"35","author":"J Stefanowicz","year":"2012","unstructured":"Stefanowicz, J. et al. Renal function and solitary kidney disease: Wilms tumour survivors versus patients with unilateral renal agenesis. Kidney Blood Press. Res. 35, 174\u2013181 (2012).","journal-title":"Kidney Blood Press. Res."},{"key":"1126_CR85","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/ki.1996.265","volume":"49","author":"BM Brenner","year":"1996","unstructured":"Brenner, B. M., Lawler, E. V. & Mackenzie, H. S. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 49, 1774\u20131777 (1996).","journal-title":"Kidney Int."},{"key":"1126_CR86","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/ndt\/gfq844","volume":"26","author":"R Westland","year":"2011","unstructured":"Westland, R., Schreuder, M. F., B\u00f6kenkamp, A., Spreeuwenberg, M. D. & Van Wijk, J. A. E. Renal injury in children with a solitary functioning kidney-the KIMONO study. Nephrology Dialysis Transplant. 26, 1533\u20131541 (2011).","journal-title":"Nephrology Dialysis Transplant."},{"key":"1126_CR87","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0140-6736(92)92683-7","volume":"340","author":"JS Najarian","year":"1992","unstructured":"Najarian, J. S., McHugh, L. E., Matas, A. J. & Chavers, B. M. 20 years or more of follow-up of living kidney donors. Lancet 340, 807\u2013810 (1992).","journal-title":"Lancet"},{"key":"1126_CR88","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/08880018.2014.887804","volume":"32","author":"SS Kishore","year":"2015","unstructured":"Kishore, S. S. et al. Function and size of the residual kidney after treatment of Wilms tumor. Pediatr. Hematol. Oncol. 32, 11\u201317 (2015).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"1126_CR89","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejca.2008.09.017","volume":"45","author":"NC Daw","year":"2009","unstructured":"Daw, N. C. et al. Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with wilms tumour. Eur. J. Cancer 45, 99\u2013106 (2009).","journal-title":"Eur. J. Cancer"},{"key":"1126_CR90","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ijrobp.2023.02.040","volume":"119","author":"MM Poppe","year":"2024","unstructured":"Poppe, M. M. et al. Kidney disease in childhood cancer survivors treated with radiation therapy: a pentec comprehensive review. Int. J. Radiat. Oncol. Biol. Phys. 119, 560\u2013574 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1126_CR91","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0959-8049(95)00618-4","volume":"32","author":"SSN De Graaf","year":"1996","unstructured":"De Graaf, S. S. N. et al. Renal function after unilateral nephrectomy for Wilms\u2019 tumour: the influence of radiation therapy. Eur. J. Cancer 32, 465\u2013469 (1996).","journal-title":"Eur. J. Cancer"},{"key":"1126_CR92","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.ijrobp.2010.03.021","volume":"80","author":"T B\u00f6lling","year":"2011","unstructured":"B\u00f6lling, T. et al. Dose-volume analysis of radiation nephropathy in children: Preliminary report of the risk consortium. Int. J. Radiat. Oncol. Biol. Phys. 80, 840\u2013844 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1126_CR93","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1016\/j.ejca.2012.06.008","volume":"48","author":"H Segers","year":"2012","unstructured":"Segers, H. et al. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients. Eur. J. Cancer 48, 3249\u20133256 (2012).","journal-title":"Eur. J. Cancer"},{"key":"1126_CR94","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1200\/JCO.21.02510","volume":"40","author":"JA Hol","year":"2022","unstructured":"Hol, J. A. et al. Prevalence of (epi)genetic predisposing factors in a 5-year unselected national wilms tumor cohort: a comprehensive clinical and genomic characterization. J. Clin. Oncol. 40, 1892\u20131902 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR95","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00467-021-05125-5","volume":"37","author":"MP Falcone","year":"2022","unstructured":"Falcone, M. P. et al. Long-term kidney function in children with wilms tumour and constitutional WT1 pathogenic variant. Pediatric Nephrol. 37, 821\u2013832 (2022).","journal-title":"Pediatric Nephrol."},{"key":"1126_CR96","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1200\/JCO.22.00411","volume":"40","author":"JT Turner","year":"2022","unstructured":"Turner, J. T., Hill, D. A. & Dome, J. S. Revisiting the threshold for cancer genetics referral in patients with wilms tumor. J. Clin. Oncol. 40, 1853\u20131860 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR97","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.urology.2014.01.051","volume":"83","author":"NG Cost","year":"2014","unstructured":"Cost, N. G. et al. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral wilms tumor. Urology 83, 1388\u20131393 (2014).","journal-title":"Urology"},{"key":"1126_CR98","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.urology.2024.12.043","volume":"198","author":"K Kieran","year":"2025","unstructured":"Kieran, K. & Shnorhavorian, M. Pediatric urologic oncology series \u2014 late effects after treatment for wilms tumor and other pediatric renal neoplasms. Urology 198, 97\u2013105 (2025).","journal-title":"Urology"},{"key":"1126_CR99","doi-asserted-by":"publisher","first-page":"8139861","DOI":"10.1155\/2016\/8139861","volume":"2016","author":"RK Kuriakose","year":"2016","unstructured":"Kuriakose, R. K., Kukreja, R. C. & Xi, L. Potential therapeutic strategies for hypertension-exacerbated cardiotoxicity of anticancer drugs. Oxid. Med. Cell Longev. 2016, 8139861 (2016).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1126_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01942-7","author":"WG Herrington","year":"2025","unstructured":"Herrington, W. G., Judge, P. K., Grams, M. E. & Wanner, C. Chronic kidney disease. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(25)01942-7 (2025).","journal-title":"Lancet"},{"key":"1126_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052237","volume":"7","author":"M van Waas","year":"2012","unstructured":"van Waas, M. et al. Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors. PLoS ONE\u00a07, e52237 (2012).","journal-title":"PLoS ONE"},{"key":"1126_CR102","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1470-2045(24)00157-8","volume":"25","author":"RA Hammoud","year":"2024","unstructured":"Hammoud, R. A. et al. The burden of cardiovascular disease and risk for subsequent major adverse cardiovascular events in survivors of childhood cancer: a prospective, longitudinal analysis from the St Jude lifetime cohort study. Lancet Oncol. 25, 811\u2013822 (2024).","journal-title":"Lancet Oncol."},{"key":"1126_CR103","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1016\/S1470-2045(23)00012-8","volume":"24","author":"MJ Ehrhardt","year":"2023","unstructured":"Ehrhardt, M. J. et al. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 24, e108\u2013e120 (2023).","journal-title":"Lancet Oncol."},{"key":"1126_CR104","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(22)02471-0","volume":"401","author":"SB Dixon","year":"2023","unstructured":"Dixon, S. B. et al. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet 401, 1447\u20131457 (2023).","journal-title":"Lancet"},{"key":"1126_CR105","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1200\/JCO.2014.56.1373","volume":"33","author":"EJ Chow","year":"2015","unstructured":"Chow, E. J. et al. Individual prediction of heart failure among childhood cancer survivors. J. Clin. Oncol. 33, 394\u2013402 (2015).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR106","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archinternmed.2010.233","volume":"170","author":"HJ Van Der Pal","year":"2010","unstructured":"Van Der Pal, H. J. et al. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch. Intern. Med. 170, 1247\u20131255 (2010).","journal-title":"Arch. Intern. Med."},{"key":"1126_CR107","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/jamaoncol.2024.6812","volume":"11","author":"A DeVine","year":"2025","unstructured":"DeVine, A. et al. The Children\u2019s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: a review. JAMA Oncol. 11, 570 (2025). Erratum in JAMA Oncol. 11(5), 570 (2025).","journal-title":"JAMA Oncol."},{"key":"1126_CR108","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejca.2021.06.021","volume":"156","author":"EC van Dalen","year":"2021","unstructured":"van Dalen, E. C. et al. Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Eur. J. Cancer 156, 127\u2013137 (2021).","journal-title":"Eur. J. Cancer"},{"key":"1126_CR109","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2019.07.006","volume":"74","author":"MY Desai","year":"2019","unstructured":"Desai, M. Y. et al. Prevention, diagnosis, and management of radiation-associated cardiac disease: JACC Scientific Expert Panel. J. Am. Coll. Cardiol. 74, 905\u2013927 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1126_CR110","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1200\/JCO.1995.13.8.1851","volume":"13","author":"NE Breslow","year":"1995","unstructured":"Breslow, N. E. et al. Second malignant neoplasms following treatment for Wilms\u2019 tumor: a report from the National Wilms\u2019 Tumor Study Group. J. Clin. Oncol. 13, 1851\u20131859 (1995).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR111","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1200\/JCO.2018.77.8589","volume":"36","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Genetic risk for subsequent neoplasms among long-term survivors of childhood cancer. J. Clin. Oncol. 36, 2078\u20132087 (2018).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR112","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/pbc.25484","volume":"62","author":"JS Lee","year":"2015","unstructured":"Lee, J. S. et al. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor. Pediatr. Blood Cancer 62, 1259\u20131264 (2015).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR113","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1210\/jc.2016-3529","volume":"102","author":"JH Lubin","year":"2017","unstructured":"Lubin, J. H. et al. Thyroid cancer following childhood low-dose radiation exposure: a pooled analysis of nine cohorts. J. Clin. Endocrinol. Metab. 102, 2575\u20132583 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1126_CR114","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S1470-2045(25)00157-3","volume":"26","author":"A Neupane","year":"2025","unstructured":"Neupane, A. et al. Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study. Lancet Oncol. 26, 806\u2013816 (2025).","journal-title":"Lancet Oncol."},{"key":"1126_CR115","doi-asserted-by":"publisher","unstructured":"Kim, J. et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in the Childhood Cancer Survivor Study. JNCI Cancer Spectr. https:\/\/doi.org\/10.1093\/jncics\/pkab007 (2021).","DOI":"10.1093\/jncics\/pkab007"},{"key":"1126_CR116","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1002\/cncr.28906","volume":"120","author":"JB Dean","year":"2014","unstructured":"Dean, J. B. & Dome, J. S. Breast cancer in wilms tumor survivors: new insights into primary and secondary prevention. Cancer 120, 3598\u20133601 (2014).","journal-title":"Cancer"},{"key":"1126_CR117","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1002\/cncr.28908","volume":"120","author":"JM Lange","year":"2014","unstructured":"Lange, J. M. et al. Breast cancer in female survivors of wilms tumor: a report from the national wilms tumor late effects study. Cancer 120, 3722\u20133730 (2014).","journal-title":"Cancer"},{"key":"1126_CR118","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/jnci\/djx235","volume":"110","author":"CJ Bright","year":"2018","unstructured":"Bright, C. J. et al. Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe. J. Natl Cancer Inst. 110, 649\u2013660 (2018).","journal-title":"J. Natl Cancer Inst."},{"key":"1126_CR119","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1200\/JCO.23.00452","volume":"42","author":"EJ Heymer","year":"2024","unstructured":"Heymer, E. J. et al. Cumulative absolute risk of subsequent colorectal cancer after abdominopelvic radiotherapy among childhood cancer survivors: a PanCareSurFup Study. J. Clin. Oncol. 42, 336\u2013347 (2024).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR120","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1200\/JCO.2011.37.8760","volume":"30","author":"K Nottage","year":"2012","unstructured":"Nottage, K. et al. Secondary colorectal carcinoma after childhood cancer. J. Clin. Oncol. 30, 2552\u20132558 (2012).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR121","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","volume":"32","author":"CS Moskowitz","year":"2014","unstructured":"Moskowitz, C. S. et al. Breast cancer after chest radiation therapy for childhood cancer. J. Clin. Oncol. 32, 2217\u20132223 (2014).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR122","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1200\/JCO.20.00562","volume":"38","author":"RL Mulder","year":"2020","unstructured":"Mulder, R. L. et al. Updated breast cancer surveillance recommendations for female survivors of childhood, adolescent, and young adult cancer from the international guideline harmonization group. J. Clin. Oncol. 38, 4194\u20134207 (2020).","journal-title":"J. Clin. Oncol."},{"key":"1126_CR123","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jama.290.4.465","volume":"290","author":"LB Travis","year":"2003","unstructured":"Travis, L. B. et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290, 465\u2013475 (2003).","journal-title":"JAMA"},{"key":"1126_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30090","volume":"70","author":"MF McAleer","year":"2023","unstructured":"McAleer, M. F. et al. Harmonica consensus, controversies, and future directions in radiotherapy for pediatric Wilms tumors. Pediatr. Blood Cancer 70, e30090 (2023).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR125","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1002\/ijc.24581","volume":"125","author":"AJ Taylor","year":"2009","unstructured":"Taylor, A. J. et al. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study. Int. J. Cancer 125, 2400\u20132405 (2009).","journal-title":"Int. J. Cancer"},{"key":"1126_CR126","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ctrv.2017.11.005","volume":"63","author":"SC Clement","year":"2018","unstructured":"Clement, S. C. et al. Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treat. Rev. 63, 28\u201339 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"1126_CR127","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1136\/gutjnl-2020-322237","volume":"70","author":"RC Reulen","year":"2021","unstructured":"Reulen, R. C. et al. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study. Gut 70, 1520\u20131528 (2021).","journal-title":"Gut"},{"key":"1126_CR128","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3390\/cells13242078","volume":"13","author":"S D\u00edaz del Moral","year":"2024","unstructured":"D\u00edaz del Moral, S., Wagner, N. & Wagner, K. D. The Wilms\u2019 tumor suppressor WT1 in cardiomyocytes: implications for cardiac homeostasis and repair. Cells 13, 2078 (2024).","journal-title":"Cells"},{"key":"1126_CR129","doi-asserted-by":"publisher","first-page":"104977","DOI":"10.1016\/j.critrevonc.2025.104977","volume":"216","author":"M Bolier","year":"2025","unstructured":"Bolier, M. et al. The influence of genetic variation on late effects in childhood cancer survivors: An updated systematic review. Crit. Rev. Oncol. Hematol. 216, 104977 (2025).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1126_CR130","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/pbc.24445","volume":"60","author":"LCM Kremer","year":"2013","unstructured":"Kremer, L. C. M. et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group. Pediatr. Blood Cancer 60, 543\u2013549 (2013).","journal-title":"Pediatr. Blood Cancer"},{"key":"1126_CR131","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41571-023-00802-w","volume":"20","author":"MJ Ehrhardt","year":"2023","unstructured":"Ehrhardt, M. J. et al. Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century. Nat. Rev. Clin. Oncol. 20, 678\u2013696 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1126_CR132","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s00467-022-05528-y","volume":"37","author":"C La Scola","year":"2022","unstructured":"La Scola, C. et al. Management of the congenital solitary kidney: consensus recommendations of the italian society of pediatric Nephrology. Pediatric Nephrol. 37, 2185\u20132207 (2022).","journal-title":"Pediatric Nephrol."},{"key":"1126_CR133","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ijrobp.2009.08.016","volume":"78","author":"IWEM Van Dijk","year":"2010","unstructured":"Van Dijk, I. W. E. M. et al. Evaluation of late adverse events in long-term Wilms\u2019 tumor survivors. Int. J. Radiat. Oncol. Biol. Phys. 78, 370\u2013378 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1126_CR134","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1573400510666141114223827","volume":"10","author":"P Gawade","year":"2014","unstructured":"Gawade, P. et al. A systematic review of selected musculoskeletal late effects in survivors of childhood cancer. Curr. Pediatr. Rev. 10, 249\u2013262 (2014).","journal-title":"Curr. Pediatr. Rev."},{"key":"1126_CR135","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S0360-3016(99)00534-9","volume":"46","author":"AC Paulino","year":"2000","unstructured":"Paulino, A. C. et al. Late effects in children treated with radiation therapy for Wilms\u2019 tumor. Int. J. Radiat. Oncol. Biol. Phys. 46, 1239\u20131246 (2000).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1126_CR136","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/pon.5584","volume":"30","author":"RH Foster","year":"2021","unstructured":"Foster, R. H. et al. Psychological, educational, and social late effects in adolescent survivors of Wilms tumor: a report from the childhood cancer survivor study. Psychooncology 30, 349\u2013360 (2021).","journal-title":"Psychooncology"},{"key":"1126_CR137","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s11764-019-00776-8","volume":"13","author":"I Tonning Olsson","year":"2019","unstructured":"Tonning Olsson, I. et al. Neurocognitive outcomes in long-term survivors of Wilms tumor: a report from the St. Jude Lifetime Cohort. J. Cancer Surviv. 13, 570\u2013579 (2019).","journal-title":"J. Cancer Surviv."},{"key":"1126_CR138","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3803\/EnM.2016.31.2.185","volume":"31","author":"JH Moon","year":"2016","unstructured":"Moon, J. H. Endocrine risk factors for cognitive impairment. Endocrinol. Metab. 31, 185\u2013192 (2016).","journal-title":"Endocrinol. Metab."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01126-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01126-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:03:26Z","timestamp":1785758606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01126-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":138,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1038\/s41585-026-01126-x","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"9 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, the email listed for Filippo Spreafico was incorrect; the email is now amended in the HTML and PDF versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}